CMS advises Discovery Life Sciences on acquisition of East West Biopharma

CMS Cameron McKenna Nabarro Olswang in Kyiv has advised Discovery Life Sciences (Discovery), a US-based bio-specimen, genomic sequencing, cell and immunohistochemistry services firm, on its acquisition of East West Biopharma, a Ukraine-based human bio-specimen solutions organisation.

The acquisition builds on Discovery’s existing capability and creates the largest network of clinical collection sites in Europe, advancing its position as the global market leader in bio-specimen procurement.

Graham Conlon, CMS partner and the Head of Private Equity for CEE/CIS, and the Managing Partner of CMS Cameron McKenna Nabarro Olswang Ukraine, comments: “We are pleased to support Discovery on this important acquisition, which demonstrates the ongoing market interest in Ukraine’s life sciences sector. CMS has a strong record advising global life sciences companies on mergers and acquisitions and, as a full-service international law firm, we are able to support our clients on all their legal needs across multiple jurisdictions.”

The CMS team was led by Graham Conlon and supported by Viktoriia Stavchuk, Louise Çakar, Ihor Pavliukov, Nataliya Nakonechna, Tetyana Dovgan, Oleksandr Sytnyk, Olga Belyakova, Olga Shenk, Mykola Heletiy, Roman Hryshyn-Hryshchuk, Denys Hatseniuk, Vladyslav Kurylko, Oleksandra Pokhvalna, Glib Bukharin, Sergiy Kulikov, Ivan Pshyk, Diana Pysarenko, Vitalii Mainarovych, Mariana Saienko, Olga Stetsenko, Kateryna Chechulina, and Orest Matviychuk.